Unity Biotechnology, Inc. (UBX) earnings
UBX earnings moved a median of -0.80% by the close. Quarterly and annual UBX reports and results, each read against the price at its own news timestamp. Back to the UBX overview →
14 measured UBX earnings events.
Where these UBX earnings landedvs 14 measured UBX earnings reactions
| Middle 50% of UBX earnings reactions | -2.69% to +1.24% |
|---|---|
| Median reaction (to close) | -0.80% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 UBX earnings events with a measured close landed between -2.69% and +1.24%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Unity Biotechnology, For: Mar 31 | SEC filing · Form 10-Q | -1.20% | -3.33% | |
| UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates | Press release | -1.20% | -3.33% | |
| Form 10-K/A Unity Biotechnology, For: Dec 31 | SEC filing · Form 10-K | +1.01% | -1.59% | |
| Form 10-K Unity Biotechnology, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 10-Q Unity Biotechnology, For: Sep 30 | SEC filing · Form 10-Q | +3.10% | +5.22% | |
| UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates | Press release | +3.10% | +5.22% | |
| Form 10-Q Unity Biotechnology, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +1.44% | |
| UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates | Press release | +0.00% | +1.44% | |
| Form 10-Q Unity Biotechnology, For: Mar 31 | SEC filing · Form 10-Q | +5.14% | +0.66% | |
| UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates | Press release | +5.14% | +0.66% | |
| Form 10-K Unity Biotechnology, For: Dec 31 | SEC filing · Form 10-K | -2.58% | -3.23% | |
| Form NT 10-K Unity Biotechnology, For: Dec 31 | SEC filing · Form NT | -0.60% | -3.01% | |
| Form 10-Q Unity Biotechnology, For: Sep 30 | SEC filing · Form 10-Q | -4.57% | -1.71% | |
| UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates | Press release | -4.57% | -1.71% |
Keep exploring
More UBX: analyst actions → · SEC filings → · UBX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IANTHUS CAPITAL HLDG ORD (ITHUF) | 105 | +2.50% | 60% |
| Supreme Cannabis Co Inc (SPRWF) | 105 | -0.13% | 41% |
| Creative Medical Technology Holdings, Inc. (CELZ) | 103 | 0.00% | 49% |
| COVALON TECHS LTD (CVALF) | 103 | 0.00% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.